Coronary Pressure Market Report 2026

The coronary pressure market size has grown strongly in recent years. It will grow from $19.08 billion in 2025 to $20.97 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing cardiovascular disease burden, hospital-based monitoring dominance, limited outpatient monitoring options, growing diagnostic procedures, reliance on invasive measurements.

The coronary pressure market size is expected to see strong growth in the next few years. It will grow to $30.38 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to advancements in wearable technology, growing homecare adoption, increased cardiac screening programs, rising preventive cardiology focus, digital health integration. Major trends in the forecast period include rising use of invasive pressure monitoring, growing adoption of wearable monitoring devices, expansion of ambulatory blood pressure monitoring, integration with cardiac diagnostic systems, increased focus on early risk assessment.

The rising prevalence of cardiovascular diseases is expected to support the growth of the coronary pressure market in the coming years. Cardiovascular diseases include a broad range of conditions that affect the heart and blood vessels, such as coronary artery disease, hypertension, and heart failure, and are often associated with lifestyle factors and genetic predisposition. The incidence of cardiovascular diseases is increasing due to factors such as unhealthy dietary habits, sedentary lifestyles, and growing obesity rates. Coronary pressure devices play an important role in the assessment and management of cardiovascular diseases by measuring pressures within the coronary arteries, supporting clinical decision-making, and improving patient outcomes. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular diseases were responsible for 919,032 deaths in 2023, accounting for approximately one in every three deaths. Coronary heart disease remained the most common form of heart disease, with nearly one in six cardiovascular-related deaths occurring among adults younger than 65 years. Therefore, the increasing burden of cardiovascular diseases is driving the growth of the coronary pressure market.

Companies operating in the coronary pressure market are increasingly focused on developing advanced solutions such as coronary intravascular lithotripsy (IVL) catheters to improve the accuracy of coronary assessments and enhance outcomes in the treatment of calcified lesions. Coronary intravascular lithotripsy catheters are balloon-based devices that generate acoustic pressure waves to break up hardened calcium deposits within coronary arteries, improving vessel compliance and enabling safer and more effective stent deployment during coronary interventions. For instance, in May 2023, Shockwave Medical Inc., a US-based cardiovascular device company, introduced the Shockwave C2+ Coronary IVL Catheter, an advanced device designed to treat severely calcified coronary lesions. The C2+ catheter consists of a balloon catheter with integrated lithotripsy emitters and is compatible with 0.014-inch guidewires and 5 Fr guiding catheters. It operates by inflating at low pressure, approximately 4 atmospheres, followed by the delivery of sonic pulses, providing 50% more pulses than the earlier C2 model, to fracture calcified plaque prior to stent placement. Key features include improved deliverability and the ability to treat longer and more complex lesions, including eccentric or nodular calcium. Its applications include pre-stent lesion preparation in complex calcified de novo coronary artery disease, offering benefits such as more predictable stent expansion, reduced reliance on high-pressure post-dilatation, and a lower risk of vessel-related complications.

In May 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical technology company, acquired Shockwave Medical Inc. for an undisclosed amount. Through this acquisition, Johnson & Johnson aims to strengthen its presence in the cardiovascular market, expand treatment options for patients, and support long-term financial growth. Shockwave Medical Inc. is a US-based company specializing in coronary pressure devices.

Major companies operating in the coronary pressure market are Cardinal Health Inc., General Electric Company, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, Omron Corporation, Edwards Lifesciences, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, AtriCure, Rossmax, A&D Medical, St. Jude Medical, HeartWare International.

North America was the largest region in the coronary pressure market in 2025. The regions covered in the coronary pressure market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary pressure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the coronary pressure market by increasing costs of imported sensors, monitoring devices, transducers, and electronic components. Hospitals and cardiac care centers in North America and Europe are most affected due to dependence on imported equipment, while Asia-Pacific faces higher device costs. These tariffs are increasing monitoring expenses. However, they are also encouraging regional device manufacturing and local innovation in cardiac monitoring solutions.

The coronary pressure market research report is one of a series of new reports that provides coronary pressure market statistics, including coronary pressure industry global market size, regional shares, competitors with a coronary pressure market share, detailed coronary pressure market segments, market trends and opportunities, and any further data you may need to thrive in the coronary pressure industry. This coronary pressure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Coronary pressure refers to the pressure within the coronary arteries that supply blood and oxygen to the heart muscle. It is an important parameter for assessing the adequacy of blood flow and oxygen delivery to the heart. Coronary pressure is influenced by factors such as heart rate, blood volume, and arterial resistance, and monitoring it plays a key role in the diagnosis and management of coronary artery disease.

The primary device types used to measure coronary pressure include sphygmomanometers, automated blood pressure monitors, blood pressure (BP) transducers, and ambulatory blood pressure monitors. A sphygmomanometer is a manual blood pressure measurement device that typically includes an inflatable cuff, a pressure gauge, and a bulb for cuff inflation. The technologies used include digital, aneroid, and wearable systems, and these devices are utilized by end users such as hospitals, cardiac care centers, ambulatory centers, homecare settings, and academic institutes.

The coronary pressure market consists of sales of fractional flow reserve (FFR) wire, instantaneous wave-free ratio (iFR) wire, pressure monitoring manifolds, and pressure measurement devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.